1-3 of 3
Appalaraju Jaggupilli
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Activin-like Kinase 2 (ALK2/ACVR1) Is a Resistance Factor and Therapeutic Vulnerability to FLT3 Inhibition in Acute Myeloid Leukemia

Anudishi Tyagi, Stanley Ly, Bin Yuan, Fouad El-Dana, Vivek Anand, Appalaraju Jaggupilli, Gautam Borthakur, Jason M Foulks, Steven L. Warner, Venkata Lokesh Battula
Journal: Blood
Blood (2022) 140 (Supplement 1): 3052–3053.
https://doi.org/10.1182/blood-2022-167580
Published: 2022
Journal Articles

Evidence supporting a role for the immune checkpoint protein B7-H3 in NK cell-mediated cytotoxicity against AML

Anudishi Tyagi, Stanley Ly, Fouad El-Dana, Bin Yuan, Appalaraju Jaggupilli, Sabrina Grimm, Marina Konopleva, Hans-Jörg Bühring, V. Lokesh Battula
Journal: Blood
Blood (2022) 139 (18): 2782–2796.
https://doi.org/10.1182/blood.2021014671
Published: 2022
Includes: Supplemental data
Journal Articles

TP-0184, a Novel FLT3-ALK2 Dual Inhibitor, Targets Amino Acid Transport and Biosynthesis in AML Cells and Sensitizes AML Cells to Chemotherapy and BCL2 Inhibition

Anudishi Tyagi, Stanley Ly, Bin Yuan, Fouad El-Dana, Appalaraju Jaggupilli, Jason M Foulks, Steven L. Warner, Venkata Lokesh Battula
Journal: Blood
Blood (2021) 138 (Supplement 1): 376.
https://doi.org/10.1182/blood-2021-151251
Published: 2021